-
Subject Areas on Research
-
"Is there an emerging need for new antifungals?".
-
50 Years of Emmonsia Disease in Humans: The Dramatic Emergence of a Cluster of Novel Fungal Pathogens.
-
A Fungal Arrestin Protein Contributes to Cell Cycle Progression and Pathogenesis.
-
A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.
-
A global call for talaromycosis to be recognised as a neglected tropical disease.
-
A nationwide survey of clinical laboratory methodologies for fungal infections.
-
A new stain for systemic fungi in tissue.
-
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
-
AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings.
-
Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation.
-
Agents for treatment of invasive fungal infections.
-
Alopecia associated with fluconazole therapy.
-
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
-
Amphotericin B: 30 years of clinical experience.
-
An Antimicrobial Peptide and Its Neuronal Receptor Regulate Dendrite Degeneration in Aging and Infection.
-
An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
-
Analysis of genes coding for small-subunit rRNA sequences in studying phylogenetics of dematiaceous fungal pathogens.
-
Anidulafungin: a new echinocandin for the treatment of fungal infections.
-
Antifungal Drugs in Newborns and Children.
-
Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.
-
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.
-
Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients.
-
Antifungal pharmacodynamics: review of the literature and clinical applications.
-
Antifungal pharmacotherapy for invasive mould infections.
-
Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
-
Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.
-
Antifungal serum concentration monitoring: an update.
-
Antifungal therapy and its use in surgical treatment.
-
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.
-
Antifungal treatment in pediatric patients.
-
Antifungals in Clinical Use and the Pipeline.
-
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
-
Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality.
-
Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa.
-
Azole antifungals: 35 years of invasive fungal infection management.
-
BacT/Alert: an automated colorimetric microbial detection system.
-
Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin.
-
Black Molds and Melanized Yeasts Pathogenic to Humans.
-
Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States.
-
Bone marrow cultures for the diagnosis of mycobacterial and fungal infections in patients infected with the human immunodeficiency virus.
-
Bony erosion patterns in patients with allergic fungal sinusitis.
-
Brain abscess caused by a variety of cladosporium trichoides.
-
Breakthrough invasive fungal infections: Who is at risk?
-
Care of Children with DiGeorge Before and After Cultured Thymus Tissue Implantation.
-
Caspofungin: first approved agent in a new class of antifungals.
-
Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985.
-
Cell biology. A fungal Achilles' heel.
-
Cerebral phaeohyphomycosis complicated with brain abscess: a case report.
-
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
-
Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.
-
Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series.
-
Clinical diagnosis of endophthalmitis.
-
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.
-
Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017.
-
Clinical impact of bacteria and fungi recovered only from broth cultures.
-
Clinical importance of "breakthrough" bacteremia.
-
Clinical importance of polymicrobial bacteremia.
-
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda.
-
Clustering of pattern recognition receptors for fungal detection.
-
Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts.
-
Combination antifungal therapy.
-
Combination antifungal therapy: what can and should we expect?
-
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
-
Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia.
-
Comparative evaluation of radiometric tryptic soy broth versus radiometric tryptic soy broth with 10% sucrose for detection of bacteremia and fungemia in pediatric patients.
-
Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae.
-
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
-
Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.
-
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
-
Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory.
-
Complications of implantable venous access devices in patients with sickle cell disease.
-
Controlled clinical comparison of bioMérieux VITAL and BACTEC NR-660 blood culture systems for detection of bacteremia and fungemia in adults.
-
Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia.
-
Controlled comparison of a new Becton Dickinson agar slant blood culture system with Roche Septi-Chek for the detection of bacteremia and fungemia.
-
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles.
-
Controlled evaluation of blood culture medium containing gelatin and V-factor-analog for detection of septicemia in children.
-
Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth.
-
Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth.
-
Controlled evaluation of modified radiometric blood culture medium supplemented with gelatin for detection of bacteremia and fungemia.
-
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia.
-
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia.
-
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth.
-
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia.
-
Controlled evaluation of trypticase soy broth with and without gelatin and yeast extract in the detection of bacteremia and fungemia.
-
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.
-
Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.
-
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States.
-
Critical care perspective on immunotherapy in lung transplantation.
-
Cryptic connections illuminate pathogen transmission within community networks.
-
Current best practices and guidelines. Assessment and management of complications in infective endocarditis.
-
Current options in antifungal pharmacotherapy.
-
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA).
-
Curvularia alcornii Infection.
-
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
-
Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
-
Development and evaluation of a real-time polymerase chain reaction assay for the rapid detection of Talaromyces marneffei MP1 gene in human plasma.
-
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment.
-
Diagnosis of fungal infection: new technologies for the mycology laboratory.
-
Diagnostic methods current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis.
-
Do not abandon amphotericin B as an antifungal bladder irrigant.
-
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling.
-
Duration of incubation of fungal cultures.
-
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
-
Dynamic duo takes down fungal villains.
-
Echinocandins for the nursery: an update.
-
Echinocandins: role in antifungal therapy, 2005.
-
Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system.
-
Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study.
-
Emerging Fungal Infections.
-
Emerging echinocandins for treatment of invasive fungal infections.
-
Emergomyces africanus in Soil, South Africa.
-
Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America.
-
Emergomyces: The global rise of new dimorphic fungal pathogens.
-
Emmonsia helica Infection in HIV-Infected Man, California, USA.
-
Endemic mycoses: geographical distribution is still a work in progress.
-
Endovascular treatment of cerebral mycotic aneurysm: a review of the literature and single center experience.
-
Environmental predictors and incubation period of AIDS-associated penicillium marneffei infection in Ho Chi Minh City, Vietnam.
-
Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.
-
Epidemiology of invasive mold infections in lung transplant recipients.
-
Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam.
-
Epithelial implantation membrane on the iris surface following cataract extraction with report of two cases.
-
Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study.
-
Evaluation and management of fungal infections in immunocompromised patients.
-
Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia.
-
Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
-
Evolution of eukaryotic microbial pathogens via covert sexual reproduction.
-
Exploiting and subverting Tor signaling in the pathogenesis of fungi, parasites, and viruses.
-
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection.
-
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
-
Fatal, disseminated Acremonium strictum infection in a neutropenic host.
-
First report of involvement of Nodulisporium species in human disease.
-
First report of urease activity in the novel systemic fungal pathogen Emergomyces africanus: a comparison with the neurotrope Cryptococcus neoformans.
-
Fungal horizons: the Asilomar Fungal Genetics Conference 2007.
-
Fungal infection following renal transplantation.
-
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.
-
Fungal infections in HIV/AIDS.
-
Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature.
-
Fungal infections in transplant and oncology patients.
-
Fungal pathogens.
-
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.
-
Fungal virulence genes as targets for antifungal chemotherapy.
-
Fungi that Infect Humans.
-
Fusarium infection in burned patients.
-
Gastrointestinal complications of renal transplantation.
-
Getting under—and through—the skin: ecological genomics of chytridiomycosis infection in frogs.
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM.
-
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.
-
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.
-
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.
-
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
-
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit.
-
Histopathology of fungal rhinosinusitis.
-
Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review.
-
Host immune responses in the central nervous system during fungal infections.
-
Immune reconstitution syndrome associated with opportunistic mycoses.
-
In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.
-
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study.
-
Infections diagnosed in the first year after pediatric stem cell transplantation.
-
Infectious complications of lung transplantation.
-
Intracranial abscess as a complication of allergic fungal sinusitis.
-
Introduction. Issues concerning antifungal susceptibility testing.
-
Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.
-
Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania.
-
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
-
Invasive mould infections: a multi-disciplinary update.
-
Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity).
-
Invasive mycoses: evolving challenges and opportunities in antifungal therapy. Introduction.
-
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
-
Is it time to abandon the use of amphotericin B bladder irrigation?
-
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
-
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
-
Key references in infectious diseases pharmacotherapy.
-
Late-onset bloodstream infections in hospitalized term infants.
-
Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
-
Lung transplantation at Duke University Medical Center.
-
Management of drug and food interactions with azole antifungal agents in transplant recipients.
-
Management of invasive mycoses in hematology patients: current approaches.
-
Management of the immunocompromised patient: impact of fungal infections. Introduction.
-
Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms.
-
Micafungin: the US perspective.
-
Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis.
-
Molecular methods for epidemiological and diagnostic studies of fungal infections.
-
Molecular typing of pathogenic fungi.
-
Mortality rates in comparative trials of formulations of amphotericin B.
-
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients.
-
Mucormycosis: time to address this deadly fungal infection.
-
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
-
Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis.
-
Mycoses in the transplanted patient.
-
Mycotic diseases. A proposed nomenclature.
-
Name changes in medically important fungi and their implications for clinical practice.
-
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ-Global Registry for Emerging Fungal Infections.
-
Neuroimaging of AIDS. I. Fungal infections of the central nervous system.
-
New antifungal agents under development in children and neonates.
-
New antifungal agents.
-
New antifungal agents.
-
New aspects of emerging fungal pathogens. A multifaceted challenge.
-
New facets of antifungal therapy.
-
Newer antifungal therapy for emerging fungal pathogens.
-
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
-
Nonmolecular methods for the diagnosis of respiratory fungal infections.
-
Nosocomial infection in the NICU: a medical complication or unavoidable problem?
-
Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales).
-
Novel use of a swimming pool biocide in the treatment of a rare fungal mastoiditis.
-
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
-
Orbitofascial conidiobolomycosis in a child.
-
Overview of basic medical mycology.
-
Overview of treatment options for invasive fungal infections.
-
Paecilomyces lilacinus septic olecranon bursitis in an immunocompetent host.
-
Paecilomyces varioti endocarditis on a prosthetic aortic valve.
-
Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.
-
Pediatric antifungal agents.
-
Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.
-
Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions.
-
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
-
Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.
-
Pharmacokinetics of antifungal agents in children.
-
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
-
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
-
Pleural space infections: microbiology and antimicrobial therapy.
-
Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy.
-
Pneumonia due to Fonsecaea pedrosoi and cerebral abscesses due to Emericella nidulans in a bone marrow transplant recipient.
-
Poor Oral Health Linked with Increased Risk of Infectious Complications in Adults with Leukemia.
-
Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei.
-
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
-
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
-
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
-
Posaconazole.
-
Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients.
-
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
-
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.
-
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
-
Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis.
-
Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort.
-
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.
-
Prophylaxis of invasive mycoses in solid organ transplantation.
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
-
Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.
-
Race and ethnicity: Risk factors for fungal infections?
-
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
-
Rapid global expansion of the fungal disease chytridiomycosis into declining and healthy amphibian populations.
-
Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.
-
Re-drawing the Maps for Endemic Mycoses.
-
Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States.
-
Recent advances in antifungal pharmacotherapy for invasive fungal infections.
-
Recent advances in the treatment of life-threatening, invasive fungal infections.
-
Recent and innovative methods for detection of bacteremia and fungemia.
-
Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989.
-
Report of the first case of invasive fungal sinusitis caused by Scopulariopsis acremonium: review of scopulariopsis infections.
-
Retrospective review of amphotericin B use in a tertiary-care medical center.
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
-
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
-
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature.
-
Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore.
-
Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.
-
Role of echinocandins in the management of fungal infections in neonates.
-
Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo.
-
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.
-
Safety of Inhaled Amphotericin B Lipid Complex as Antifungal Prophylaxis in Lung Transplant Recipients.
-
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
-
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
-
Sensing the environment: lessons from fungi.
-
Sexual reproduction of human fungal pathogens.
-
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study.
-
Signaling cascades as drug targets in model and pathogenic fungi.
-
Sinusitis caused by the fungus Xylaria enteroleuca in a lung transplant recipient.
-
Soft-tissue fungal infections: surgical management of 12 immunocompromised patients.
-
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
-
Species and genotypic diversities and similarities of pathogenic yeasts colonizing women.
-
Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
-
Status of medical mycology education.
-
Strategies to manage antifungal drug resistance.
-
Study of renal safety in amphotericin B lipid complex-treated patients.
-
Successful management of a simultaneous Aspergillus fumigatus and Absidia corymbifera invasive fungal infection.
-
Successful treatment of Ochroconis gallopavum infection in an immunocompetent host.
-
Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient.
-
Superiority of a Novel Mp1p Antigen Detection Enzyme Immunoassay Compared to Standard BACTEC Blood Culture in the Diagnosis of Talaromycosis.
-
Synthesis and antifungal activities of miltefosine analogs.
-
Systemic infection by fusarium in a burned child. The emergence of a saprophytic strain.
-
Talaromyces marneffei promotes M2-like polarization of human macrophages by downregulating SOCS3 expression and activating the TLR9 pathway.
-
Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs.
-
The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
-
The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary.
-
The Rise of Fungi: A Report on the CIFAR Program Fungal Kingdom: Threats & Opportunities Inaugural Meeting.
-
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations.
-
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.
-
The current state of Clinical Mycology in Eastern and South-Eastern Europe.
-
The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam.
-
The economic costs to United States hospitals of invasive fungal infections in transplant patients.
-
The future of fungi: threats and opportunities.
-
The impact of the host on fungal infections.
-
The new fungal opportunists are coming.
-
The potential impact of excluding funguria from the surveillance definition of catheter-associated urinary tract infection.
-
The spectrum of fungi that infects humans.
-
The use of amphotericin B in nosocomial fungal infection.
-
The virulence of human pathogenic fungi: notes from the South of France.
-
Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture.
-
Torulopsis glabrata fungemia--a clinical pathological study.
-
Transposon mobilization in the human fungal pathogen Cryptococcus is mutagenic during infection and promotes drug resistance in vitro.
-
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
-
Trehalose pathway as an antifungal target.
-
Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.
-
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
-
Uncommon invasive fungal pathogens in the acquired immunodeficiency syndrome.
-
Uncovering scaling laws to infer multidrug response of resistant microbes and cancer cells.
-
Unusual fungal pathogens in fungal rhinosinusitis.
-
Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients.
-
Use of newer antifungal therapies in clinical practice: what do the data tell us?
-
Very late onset infections in the neonatal intensive care unit.
-
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
-
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
-
When primary antifungal therapy fails.
-
Keywords of People
-
-
-
Bradford, William Dalton,
Professor of Pathology,
Pathology
-
Cohen-Wolkowiez, Michael,
Professor of Pediatrics,
Pediatrics, Infectious Diseases
-
Le, Thuy,
Associate Professor of Medicine,
Molecular Genetics and Microbiology
-
Schwartz, Ilan,
Instructor in the Department of Medicine,
Medicine, Infectious Diseases
-
Shinohara, Mari L.,
Associate Professor of Immunology,
Cell Biology
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology
-
Woodward, Julie Ann,
Professor of Ophthalmology,
Dermatology